GITNUX MARKETDATA REPORT 2024
Xarelto Pre-Surgery Holding Period Statistics
Xarelto should ideally be stopped 24 hours before surgery to minimize the risk of bleeding complications.
Statistic 1
"Approximately 2-3% of patients experience major bleeding when not appropriately managing the Xarelto holding period."
Statistic 2
"Xarelto has a half-life of approximately 5-9 hours in young people and 11-13 hours in older patients."
Statistic 3
"Discontinuation of Xarelto may be accompanied by bridging with heparin in patients at high risk of thrombosis."
Statistic 4
"Only 53% of patients receive proper guidelines for the management of Xarelto before surgery."
Statistic 5
"Restarting Xarelto post-surgery should typically occur 24-72 hours after surgery, depending on hemostasis."
Statistic 6
"The use of Xarelto has been associated with a lower risk of perioperative complications compared to Warfarin when managed correctly."
Statistic 7
"Bridging anticoagulation therapy is generally not recommended when holding Xarelto pre-surgery."
Statistic 8
"Consultations with the surgical and prescribing teams are essential when deciding the holding period of Xarelto."
Statistic 9
"Guidelines recommend periodic reevaluation of bleeding risk in patients on Xarelto undergoing surgery."
Statistic 10
"The recommended holding period for Xarelto before elective surgery is typically 24 to 48 hours."
Statistic 11
"For minor dental procedures, holding Xarelto might not be necessary according to certain guidelines."
Statistic 12
"Guidelines advise considering the type and timing of surgery to determine the Xarelto holding period."
Statistic 13
"The risk of major bleeding complications during surgery is significantly reduced when Xarelto is held appropriately."
Statistic 14
"Studies show that inappropriate management of Xarelto increases perioperative thromboembolic events by 1.5 times."
Statistic 15
"Xarelto is often held for longer periods in patients with renal impairment, up to 72 hours."
Statistic 16
"The rate of perioperative ischemic events in patients on Xarelto who followed pre-surgery holding guidelines is below 2%."
Statistic 17
"The perioperative management of Xarelto should be assessed individually based on renal function and bleeding risk."
Statistic 18
"Patient-specific factors, such as age and comorbidities, significantly influence the Xarelto holding period."
Statistic 19
"Xarelto should be stopped at least 24 hours prior to surgeries with a high bleeding risk."
Statistic 20
"The management of Xarelto pre-surgery is part of broader anticoagulation best practices."